See the AVEIR VR Leadless Pacemaker in action 

Read more to learn how AVEIR™ VR LP has helped patients with a broad spectrum of health concerns live healthier, better lives.

AVEIR VR LP is an appropriate choice for patients indicated for permanent pacing but who may need temporary or interim pacing support following certain types of procedures like laser lead extractions (LLEs) and TAVR. For these patients, AVEIR offers: 

• Retrievability - the device allows for safe and effective pacing while being treated
• Flexibility- In the face of uncertain conduction system impacts post-TAVR, AVEIR VR LP allows for flexibility of treatment depending on patient need
• The LP device electronics are designed to be enabled by future software, upon regulatory approval, to support dual chamber pacing in the future.*

Learn more about how AVEIR VR LP has helped patients like this. 

For patients with symptomatic AV block who have persistent atrial fibrillation (AF) or other atrial tachyarrhythmia (AT). AVEIR VR LP can provide: 

• Pacing support for AVB; and
• Retrievability for upgrades in the event of disease progression
• The LP device electronics are designed to be enabled by future software, upon regulatory approval, to support dual chamber pacing in the future.*

Learn more about how AVEIR VR LP has helped patients like this. 

AVEIR VR LP is an effective solution for this group of patients, e.g. patients in normal sinus rhythm with episodes of sinus arrest and in whom relatively infrequent ventricular pacing is expected, or who have significant existing comorbidities that are otherwise likely to impact or determine clinical outcomes. For these patients, AVEIR VR LP offers: 

• Retrievability 
• Long-lasting battery
• The LP device electronics are designed to be enabled by future software, upon regulatory approval, to support dual chamber pacing in the future.*
• If the patient is young and active, no risk of leads being damaged

Learn more about how AVEIR VR LP has helped patients like this. 

Patients in this category may include those experiencing symptomatic intermittent AV block, those with AV block in whom infrequent pacing is expected, or who have significant existing comorbidities that are otherwise likely to impact or determine clinical outcomes. AVEIR VR LP is appropriate for these patients because: 

• Intermittent ventricular pacing will be required, and
• The LP device electronics are designed to be enabled by future software, upon regulatory approval, to support dual chamber pacing in the future.*

Learn more about how AVEIR VR LP has helped patients like this. 

Patients in this category may experience symptomatic pauses secondary to persistent or chronic atrial fibrillation, slow ventricular response or malignant tachy-brady syndrome, severe comorbidities like end-stage kidney disease¹ (ESKD) or access and mobility problems that would support leadless pacing as the preferred pacing option.

AVEIR VR LP is an appropriate option for these patients because: 

• No AV synchrony required with this indication
• Addresses access concerns
• Eliminates risk of lead complications and reduces follow-on infection and complication risk¹

Learn more about how AVEIR VR LP has helped patients like this.